Don Crawford

Don is a seasoned medical device executive with over 40 years of experience in cardiovascular diagnostics. Prior to joining AccuLine, Don served as the President & CEO of CorVista Health for nine years, where he successfully raised over $115 million and secured FDA approval for its AI-powered cardiac diagnostic platform. Before CorVista, Don was the founder and CEO of Sapheon, a pioneering venous disease treatment company, which was acquired by Covidien for $238 million. Don has also held senior leadership roles at Medtronic, Guidant, Ventritex, and Intermedics, managing international sales and marketing. His extensive expertise in fundraising, market expansion, and regulatory strategy has positioned him as a key leader in the MedTech industry. With a strong track record of guiding medical device companies through development, approval, and commercialization, Don brings invaluable experience to AccuLine’s mission to revolutionize cardiovascular diagnostics. Don holds a B.Ch.E. in Chemical Engineering from Georgia Tech and an M.B.A. from Emory University. He also has dozens of patents to his name.